Literature DB >> 12810098

The Toll-IL-1 receptor adaptor family grows to five members.

Luke A J O'Neill1, Katherine A Fitzgerald, Andrew G Bowie.   

Abstract

Toll-like receptor (TLR) signal transduction is mediated by an adaptor protein termed MyD88. In the case of TLR2 and TLR4, another adaptor related to MyD88 called Mal also participates in signalling. Two recent papers have added a third adaptor to the family, called Toll-interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (IFN-beta) (TRIF) or TIR-containing adaptor molecule-1 (TICAM-1), which is particularly important for IFN regulatory factor-3 (IRF-3) activation by antiviral TLR3. Two additional adaptors are present in humans, termed Trif-related adaptor molecule (TRAM) and sterile alpha and HEAT-Armadillo motifs (SARM). It is probable that differential use of adaptors will help explain the distinct pathways activated by TLRs during host defence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810098     DOI: 10.1016/s1471-4906(03)00115-7

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  109 in total

Review 1.  Bacterial inhibition of eukaryotic pro-inflammatory pathways.

Authors:  Andrew S Neish
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Antimicrobial peptides inhibit polyinosinic-polycytidylic acid-induced immune responses.

Authors:  Maroof Hasan; Catarina Ruksznis; Yan Wang; Cynthia Anne Leifer
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

3.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

4.  Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.

Authors:  Kenya Honda; Hideyuki Yanai; Tatsuaki Mizutani; Hideo Negishi; Naoya Shimada; Nobutaka Suzuki; Yusuke Ohba; Akinori Takaoka; Wen-Chen Yeh; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

Review 5.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 6.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Genetic analysis of Toll/Interleukin-1 Receptor (TIR) domain sequences from rhesus macaque Toll-like receptors (TLRs) 1-10 reveals high homology to human TLR/TIR sequences.

Authors:  Sonali K Sanghavi; Raj Shankarappa; Todd A Reinhart
Journal:  Immunogenetics       Date:  2004-11-11       Impact factor: 2.846

8.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  HangAmDan-B, an ethnomedicinal herbal mixture, suppresses inflammatory responses by inhibiting Syk/NF-κB and JNK/ATF-2 pathways.

Authors:  Tao Yu; Sang Hyun Moh; Sang-Bom Kim; Yanyan Yang; Eunji Kim; Yeon-Weol Lee; Chong-Kwan Cho; Kyung-Hee Kim; Byong Chul Yoo; Jae Youl Cho; Hwa-Seung Yoo
Journal:  J Med Food       Date:  2012-12-20       Impact factor: 2.786

10.  Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL.

Authors:  Dola Sengupta; Alicia Koblansky; Jennifer Gaines; Tim Brown; A Phillip West; Dekai Zhang; Tak Nishikawa; Sung-Gyoo Park; R Martin Roop; Sankar Ghosh
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.